Literature DB >> 7660074

Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections.

A Norrby-Teglund1, K Pauksens, M Norgren, S E Holm.   

Abstract

The multiorgan failure syndrome caused by group A streptococci (GAS) designated streptococcal toxic shock syndrome (STSS) is believed to be mediated by cytokines induced by superantigens. In order to study the relationship between superantigen production, cytokine levels in patient sera, and clinical GAS manifestation we examined acute-phase sera and strains from 25 patients with GAS bacteremia. The patients had various disease manifestations, including STSS (44%), erysipelas (28%), septicemia (24%), wound infections (16%), and pneumonia (12%). Serotype T1M1 dominated, representing 56% of the isolates, but also strains of other serotypes were identified. The strains were found to produce the streptococcal pyrogenic exotoxins (Spe) A, B, and F, as determined by immuno-blot analyses. There was no difference in amounts of toxin produced between strains isolated from patients with different manifestations of disease. Levels of TNF alpha, IL1 alpha, IL6, IL8, and IFN gamma in acute-phase sera were determined by use of ELISA and RIA assays. The analyses showed higher levels of IL6 in sera from patients with STSS than in sera from patients with bacteremia without shock. TNF alpha was elevated in sera from patients with STSS, as compared to sera from patients with uncomplicated pharyngotonsillitis. No increase in the levels of IL1 alpha, IL8, and IFN gamma could be found in the patient sera and there was no difference in the level of those cytokines between the various patient categories.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660074     DOI: 10.3109/00365549509018991

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  23 in total

1.  Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Authors:  H Müller-Alouf; T Proft; T M Zollner; D Gerlach; E Champagne; P Desreumaux; C Fitting; C Geoffroy-Fauvet; J E Alouf; J M Cavaillon
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Therapeutic Approaches to Streptococcal Toxic Shock Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

3.  Lipopolysaccharide triggers invasive streptococcal disease in mice through a tumour necrosis factor-alpha-dependent mechanism.

Authors:  Hongyan Diao; Masashi Kohanawa; Hirofumi Nakajima; Yuichiro Sato; Tomonori Minagawa; Akio Nakane
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

4.  Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes.

Authors:  E Burlet; H HogenEsch; A Dunham; G Morefield
Journal:  AAPS J       Date:  2017-03-10       Impact factor: 4.009

5.  Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease.

Authors:  E H Burns; A M Marciel; J M Musser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

6.  Synergistic effects of streptolysin S and streptococcal pyrogenic exotoxin B on the mouse model of group A streptococcal infection.

Authors:  Chih-Hsin Hung; Nina Tsao; Yi-Fang Zeng; Shiou-Ling Lu; Chiang-Ni Chuan; Yee-Shin Lin; Jiunn-Jong Wu; Chih-Feng Kuo
Journal:  Med Microbiol Immunol       Date:  2012-05-18       Impact factor: 3.402

7.  Characterization of pneumonia due to Streptococcus equi subsp. zooepidemicus in dogs.

Authors:  Simon L Priestnall; Kerstin Erles; Harriet W Brooks; Jacqueline M Cardwell; Andrew S Waller; Romain Paillot; Carl Robinson; Alistair C Darby; Matthew T G Holden; Sandra Schöniger
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

8.  Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production.

Authors:  Hongyan Diao; Masashi Kohanawa
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

9.  The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model.

Authors:  Hong Sjölinder; Lena Lövkvist; Laura Plant; Jens Eriksson; Helena Aro; Allison Jones; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

10.  tRNA modification by GidA/MnmE is necessary for Streptococcus pyogenes virulence: a new strategy to make live attenuated strains.

Authors:  Kyu Hong Cho; Michael G Caparon
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.